Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #12,331 to #12,380.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Current events (1 revision)
  2. Curtin-Hammett principle (1 revision)
  3. Curve fitting (1 revision)
  4. Curve of spee (1 revision)
  5. Cushing's syndrome case study one (1 revision)
  6. Cushing's triad (1 revision)
  7. Cushing’s disease historical perspective (1 revision)
  8. Cushing’s disease medical therapy (1 revision)
  9. Cusp (dentistry) (1 revision)
  10. Cusp of Carabelli (1 revision)
  11. Cutaneous innervation of the upper limbs (1 revision)
  12. Cutaneous skin tags (patient information) (1 revision)
  13. Cuticle (1 revision)
  14. Cutis marmorata (1 revision)
  15. Cyan radiation astronomy (1 revision)
  16. Cyanate (1 revision)
  17. Cyanic acid (1 revision)
  18. Cyanocobalamin Injection (patient information) (1 revision)
  19. Cyanocobalamin Nasal (patient information) (1 revision)
  20. Cyanogen bromide (1 revision)
  21. Cyanogen halide (1 revision)
  22. Cyanotic heart defect CT (1 revision)
  23. Cyanotic heart defect MRI (1 revision)
  24. Cyanotic heart defect case study one (1 revision)
  25. Cyanotic heart defect cost-effectiveness of therapy (1 revision)
  26. Cyanotic heart defect diagnostic study of choice (1 revision)
  27. Cyanotic heart defect future or investigational therapies (1 revision)
  28. Cyanotic heart defect interventions (1 revision)
  29. Cyanotic heart defect other imaging findings (1 revision)
  30. Cyanotic heart defect secondary prevention (1 revision)
  31. Cyanotoxin (1 revision)
  32. Cyanthoate (1 revision)
  33. Cybernetics (1 revision)
  34. Cyborg (1 revision)
  35. Cycasin (1 revision)
  36. Cyclamate (1 revision)
  37. Cyclazocine (1 revision)
  38. Cyclic ADP-ribose (1 revision)
  39. Cyclic AMP receptors (1 revision)
  40. Cyclic guanosine monophosphate (1 revision)
  41. Cyclic nucleotide-gated channel alpha 1 (1 revision)
  42. Cyclic nucleotide-gated channel alpha 3 (1 revision)
  43. Cyclic nucleotide-gated channel alpha 4 (1 revision)
  44. Cyclic nucleotide-gated ion channel (1 revision)
  45. Cyclic peptide (1 revision)
  46. Cyclic vomiting syndrome (patient information) (1 revision)
  47. Cyclic vomiting syndrome diagnostic criteria (1 revision)
  48. Cyclic vomiting syndrome epidemiology and demographics (1 revision)
  49. Cyclic vomiting syndrome history and symptoms (1 revision)
  50. Cyclic vomiting syndrome natural history, complications and prognosis (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)